Literature DB >> 6282193

Lack of interference of guanosine with ribavirin aerosol treatment of influenza A infection in mice.

V Knight, S Z Wilson, D W Alling, R V Moore, R M Longoria.   

Abstract

Guanosine or guanosine 5'-monophosphate did not reduce the protective effect of ribavirin aerosol in influenza virus A/Aichi/68 H3N2 infection of mice. Both compounds partially interfered with the action of a wide range of ribavirin concentrations against influenza virus A/WSN replication in cell culture.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6282193      PMCID： PMC181726          DOI： 10.1128/AAC.20.4.477

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  The broad spectrum antiviral agent ribavirin inhibits capping of mRNA.

Authors:  B B Goswami; E Borek; O K Sharma; J Fujitaki; R A Smith
Journal:  Biochem Biophys Res Commun       Date:  1979-08-13       Impact factor: 3.575

2.  Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate.

Authors:  B Eriksson; E Helgstrand; N G Johansson; A Larsson; A Misiorny; J O Norén; L Philipson; K Stenberg; G Stening; S Stridh; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.

Authors:  D G Streeter; J T Witkowski; G P Khare; R W Sidwell; R J Bauer; R K Robins; L N Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

4.  Inhibition of influenza RNA synthesis by virazole (ribavirin).

Authors:  C Scholtissek
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574
  4 in total
  7 in total

Review 1.  Biochemistry and clinical applications of ribavirin.

Authors:  B E Gilbert; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

2.  Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells.

Authors:  P Toltzis; A S Huang
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

3.  Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus.

Authors:  B E Gilbert; P R Wyde; S Z Wilson; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

4.  Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.

Authors:  J J Kirsi; J A North; P A McKernan; B K Murray; P G Canonico; J W Huggins; P C Srivastava; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

5.  Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity.

Authors:  D F Smee; P A McKernan; L D Nord; R C Willis; C R Petrie; T M Riley; G R Revankar; R K Robins; R A Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

6.  Ribavirin Inhibits Parrot Bornavirus 4 Replication in Cell Culture.

Authors:  Jeffrey M B Musser; J Jill Heatley; Anastasia V Koinis; Paulette F Suchodolski; Jianhua Guo; Paulina Escandon; Ian R Tizard
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

Review 7.  Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations.

Authors:  Daniel Todt; Stephanie Walter; Richard J P Brown; Eike Steinmann
Journal:  Viruses       Date:  2016-10-13       Impact factor: 5.048
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.